期刊名称：SKIN PHARMACOLOGY AND PHYSIOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Skin Pharmacology and Physiology
Journal of Pharmacological and Biophysical Research
Editor(s): Lademann J. (Berlin)
Open access to all articles relevant for the current impact factor: 2.885
Aims and Scope
In the past decade research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as 'cosmeceuticals' in the United States, 'quasi-drugs' in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. Dermatologists, pharmaceutical chemists, pharmacologists, toxicologists, and others interested in the subject are invited to contribute to this exciting project and to submit their best research work for publication.
Bibliographic Details
Skin Pharmacology and Physiology
Journal Abbreviation: Skin Pharmacol Physiol
ISSN: 1660-5527 (Print)
e-ISSN: 1660-5535 (Online)
www.karger.com/SPP
Indexing/Abstracting
Listed in bibliographic services, including Current Contents/Life Sciences, Pubmed/MEDLINE, Biological Abstracts.
History
Founded in 1988 by H. Schaefer as ‘Skin Pharmacology’
Edited 1993–2002 by H.F. Merk
1998–2003 ‘Skin Pharmacology and Applied Skin Physiology’
Incorporating ‘Bioengineering and the Skin’
Instructions to Authors
Guidelines for Authors
www.karger.com/spp_guidelines
Submission
Conditions
Short Communications
Conflicts of Interest
Ethics
Plagiarism Policy
Arrangement
Color Illustrations
References
Digital Object Identifier (DOI)
Supplementary Material
Author's ChoiceTM, NIH-Funded Research, Self-Archiving
Page Charges
Proofs
Reprints
Submission
Manuscripts written in English should be submitted to:
Should you have any problems with your submission, please contact the Editorial Office:
spp@karger.com
Professor Dr. med. J. Lademann
Editorial Office ‘Skin Pharmacology and Physiology’
S. Karger AG
PO Box
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1361
Fax +41 61 306 1434
Conditions
All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of ‘Skin Pharmacology and Physiology’ and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications. The journal consists of the following sections:
- Editorials
- Reviews
- Original Papers
- Short Communications
- Letters to the Editor
Short Communications
Authors may apply to have their paper treated as a short communication. Condition for this is a brief definite report of important results. Final decision whether a paper will be published as a short communication will be made by the Editors. A publication time of two months after acceptance is intended.
Conflicts of Interest
Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.
Ethics
Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.
Plagiarism Policy
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).
Arrangement
Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.
Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: Please supply 3–10 key words in English that reflect the content of the paper.
Abstract: Each paper needs an abstract in English of up to 10 lines. The abstract is of utmost importance. It should contain the following information: purpose of the study, procedures, results, conclusions and message of the paper.
Footnotes: Avoid footnotes.
Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be sent in separate files. Tables require a heading and figures a legend, also in a separate file. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm). Black and white half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi.
Color Illustrations
Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 800.00 per page.
References
In the text, identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).
|
Examples
(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:
14–18.
(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
(c) Monographs: Matthews DE, Farewell VT:
Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.
(d) Edited books: Parren PWHI, Burton DR:
DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137.
|
Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
Supplementary Material
Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the data cannot be converted properly to a PDF file), and video files (.mov, .avi, .mpeg).
Author's ChoiceTM
Karger's Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
NIH-Funded Research
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits your manuscript on your behalf to PubMed Central (PMC) immediately upon publication. It usually receives a PMCID within approximately a month and will appear in PMC after 12 months. For those selecting our premium Author's ChoiceTM service, the usual embargo will be overridden, accelerating the accessibility of your work. More details on NIH's Public Access Policy are available here.
Self-Archiving
Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's Author's ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links.
Page Charges
There are no page charges for papers of 5 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.00. The allotted size of a paper is equivalent to approximately 15 double-spaced manuscript pages (including abstract, tables, illustrations and references).
Proofs
Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.
Reprints
Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.
Editorial Board
Editor
J. Lademann, Berlin
Honorary Editor
H.F. Merk, Aachen
Associate Editors
P.M. Elias, San Francisco, Calif.
J.W. Fluhr, Berlin
H.I. Maibach, San Francisco, Calif.
H. Mukhtar, Madison, Wisc.
G.J. Nohynek, Asnières
M. Roberts, Brisbane
C. Surber, Basel
P.C.M. van de Kerkhof, Nijmegen
Editorial Board Members
N. Ahmad, Madison, Wisc.
C. Antoniou, Athens
J.M. Baron, Aachen
E. Benfeldt, Roskilde
E. Berardesca, Rome
K. De Paepe, Brussels
P. Elsner, Jena
A. Farkas, Szeged
M.W. Greaves, London
R.H. Guy, Bath
E.M. Jackson, Bonney Lake, Wash.
H. Kandárová, Ashland, Mass.
L. Kemeny, Szeged, Hungary
J. Kresken, Viersen
J. Krutmann, Düsseldorf
S. Küchler, Berlin
B. Lange-Asschenfeldt, Klagenfurt am Wörthersee
R. Neubert, Halle
T. Ruzicka, Munich
M. Schäfer-Korting, Berlin
M. Schmuth, Innsbruck, Austria
S. Seidenari, Modena
P.W. Wertz, Iowa Ctiy
J. Wohlrab, Halle
L. Zastrow, Monaco
|
